Quantum-Si incorporated (QSI)
NasdaqGM · USD · Healthcare · Medical Devices
$1.46 (+4.29%) as of
Key statistics
- Market cap
- 319.57M
- Forward P/E
- -4.17
- EPS (TTM)
- -0.4500
- Dividend yield
- 0.00%
- 52-week range
- 0.6900 – 2.3200
- Beta
- 3.22
- Revenue (TTM)
- 1.6M
- Profit margin
- 0.00%
- Analyst target
- $2.28
- Volume
- 10.27M
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Branford, CT, United States
- Employees
- 145
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.